The present invention relates to a novel .alpha.-catenin with a new,
specific expression pattern in mainly heart and testis. The invention
further relates to the use of this .alpha.-catenin in the prediction,
diagnosis, and/or treatment of cadherin-catenin related diseases, in
particular cardiomyopathies and male infertility.